Get the Stockscreener App
1.36
2.16%
-0.03
Opko Health Inc stock is traded at $1.36, with a volume of 553.77K.
It is down -2.16% in the last 24 hours and down -14.47% over the past month.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
See More
Previous Close:
$1.39
Open:
$1.37
24h Volume:
553.77K
Relative Volume:
0.27
Market Cap:
$1.02B
Revenue:
$581.12M
Net Income/Loss:
$-212.92M
P/E Ratio:
-4.9671
EPS:
-0.2738
Net Cash Flow:
$-174.22M
1W Performance:
-13.38%
1M Performance:
-14.47%
6M Performance:
+14.29%
1Y Performance:
-12.26%
1-Day Range:
$1.34
$1.375
1-Week Range:
$1.375
$1.59
52-Week Range:
$0.9769
$1.75
Opko Health Inc Stock (OPK) Company Profile
Name
Opko Health Inc
Sector
Industry
Phone
305-575-4181
Address
4400 BISCAYNE BLVD., MIAMI, FL
Compare OPK vs TMO, DHR, NTRA, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.36 | 1.02B | 581.12M | -212.92M | -174.22M | -0.2738 |
TMO
Thermo Fisher Scientific Inc
|
640.67 | 236.89B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
212.45 | 149.35B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
385.18 | 55.52B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
165.05 | 46.53B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
423.38 | 41.60B | 3.77B | 449.25M | 240.68M | 7.8556 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-29-26 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Nov-20-25 | Initiated | JP Morgan | Neutral |
| Oct-31-25 | Downgrade | Jefferies | Buy → Hold |
| Apr-25-25 | Initiated | JP Morgan | Neutral |
| Jun-29-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Dec-15-22 | Initiated | H.C. Wainwright | Buy |
| Jan-24-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jun-21-21 | Initiated | Ladenburg Thalmann | Buy |
| Nov-25-19 | Initiated | Piper Jaffray | Overweight |
| Mar-02-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Sep-14-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-21-16 | Reiterated | Standpoint Research | Buy |
| Jun-03-16 | Initiated | Standpoint Research | Buy |
| Mar-31-16 | Reiterated | Barrington Research | Outperform |
| Oct-16-15 | Initiated | JP Morgan | Overweight |
| Sep-11-15 | Downgrade | Jefferies | Buy → Hold |
| Mar-03-15 | Downgrade | Oppenheimer | Outperform → Perform |
| May-12-14 | Reiterated | Oppenheimer | Outperform |
| Mar-14-14 | Initiated | Oppenheimer | Outperform |
| Nov-13-13 | Reiterated | Ladenburg Thalmann | Buy |
| May-30-13 | Reiterated | Ladenburg Thalmann | Buy |
| Oct-22-12 | Initiated | Barrington Research | Outperform |
| Dec-01-11 | Reiterated | Ladenburg Thalmann | Buy |
| Jul-14-11 | Initiated | Ladenburg Thalmann | Buy |
View All
Opko Health Inc Stock (OPK) Latest News
OPKO Health stock gets Zacks upgrade while shares fall 4.79 percent - AD HOC NEWS
BDX Expands U.S. Manufacturing With $19B Healthcare Investment - Zacks Investment Research
Reasons to Add Globus Medical Stock to Your Portfolio Now - Zacks Investment Research
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now - TradingView
OPKO Health, Inc. (NASDAQ:OPK) Stock Now Rated "Hold" by Sell-Side Analysts - MarketBeat
795,716 Shares in OPKO Health, Inc. $OPK Bought by Bank of America Corp DE - MarketBeat
OPKO Health (NASDAQ:OPK) Stock Rating Upgraded by Zacks Research - MarketBeat
OPK4048118 Bond Profile: Coupon and Redemption - TradingView
OPKO Health, Inc. (OPK) stock price, news, quote and history - Yahoo Finance Australia
OPKO Health, Inc. (OPK) Stock Price, News, Quote & History - Yahoo! Finance Canada
Here's Why You Should Retain OPK Stock in Your Portfolio for Now - TradingView
Here's Why You Should Retain OPK Stock in Your Portfolio for Now - TradingView
OPK5991654 Bond Profile: Coupon and Redemption - TradingView
Promising Penny Stocks To Watch In September 2026 - simplywall.st
OPKO Health (NASDAQ:OPK) Reaches New 12-Month HighShould You Buy? - marketbeat.com
OPKO Health, Inc. (OPK) stock price, news, quote and history - Yahoo Finance Singapore
Opko Health stock hits 52-week high at 1.74 USD - Investing.com
OPK Stock Climbs 32.5% YTD: What's Driving the Rally in 2026? - Yahoo Finance
The Bull Case For OPKO Health (OPK) Could Change Following New Mazdutide Royalty-Backed Financing Strategy - Yahoo Finance
OPKO Health (OPK) Cashes In A Future Royalty Stream Early - Yahoo Finance
OPKO Health (OPK) Stock Looks Rich As Cash Flow Risks Cloud Fair Value - webull.com
OPKO Health Pivots to Therapeutics, Eyes Data-Rich 12 to 18 Months - MarketBeat
OPKO Health Pivots to Therapeutics, Eyes Data-Rich 12 to 18 Months - Yahoo Finance
OPKO Health at Wells Fargo conference: cash-rich pivot to therapeutics - Investing.com Canada
OPKO Health (OPK) Short Interest & Short Float | Updated Sep 2026 $OPK - MarketBeat
Bank of New York Mellon Corp Takes Position in OPKO Health, Inc. $OPK - MarketBeat
OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference - OPKO Health, Inc.
OPKO Health, Inc. (NASDAQ:OPK) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference - Yahoo Finance
A healthcare conference will feature two OPKO executives on Sept. 10 - Stock Titan
OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference - GlobeNewswire
Steris (STE) Down 2.1% Since Last Earnings Report: Can It Rebound? - Zacks Investment Research
OPKO Health, Inc. Revenue Breakdown – TRADEGATE:XCY - TradingView
OPK - Finviz
OPKO Health (NASDAQ:OPK) Sets New 1-Year HighHere's Why - MarketBeat
OPKO Health (NASDAQ:OPK) Trading Up 8.2%Here's Why - MarketBeat
BlackRock Inc. Takes Position in OPKO Health, Inc. $OPK - MarketBeat
Opko Health Inc (OPK) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
Income Statement - OPKO Health, Inc.
Opko Health Inc (OPK) Peer Comparison – Compare with Others - valueresearchonline.com
Why Is OPKO Health (OPK) Down 9.7% Since Last Earnings Report? - Yahoo Finance
AWM Investment Company Inc. Makes New Investment in OPKO Health, Inc. $OPK - MarketBeat
Here's Why You Should Retain OPK Stock in Your Portfolio for Now - Yahoo Finance
COCP: 5 Million Private Placement with OPKO Health - Smartkarma
Is OPK Worth Buying as Valuation Meets Improving Business Trends? - Zacks Investment Research
Is OPK Worth Buying as Valuation Meets Improving Business Trends? - Zacks Investment Research
OPK Raises $125 Million Against Royalties: What Investors Should Know - Eastern Progress
Is OPK Worth Buying as Valuation Meets Improving Business Trends? - Yahoo Finance
OPK Climbs 12.4% in the Past Month: Can the Stock Rally Keep Going? - TradingView
Zacks Research Has Positive View of OPKO Health Q3 Earnings - MarketBeat
Opko Health Inc Stock (OPK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Opko Health Inc Stock (OPK) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 21 '25 |
Buy |
1.33 |
580,000 |
768,807 |
216,706,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 20 '25 |
Buy |
1.33 |
580,000 |
771,328 |
216,126,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 19 '25 |
Buy |
1.31 |
580,000 |
759,115 |
215,546,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 18 '25 |
Buy |
1.27 |
533,300 |
678,906 |
214,966,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Oct 31 '25 |
Buy |
1.42 |
150,000 |
213,435 |
214,386,448 |
0.08%
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):